MedTrace Logo

Using Genomic Analysis to Guide Individual Treatment in Glioblastoma

NCT02725684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2017-10-25

No results posted yet for this study

Summary

The purpose of this study is to assess whether the use of genomics can help identify patient specific treatment choices in cancer. In order to test this, the investigators plan to use genomic sequencing technology to identify patient specific mutations in glioblastoma multiforme (GBM) as compared to normal cells to identify mutations. Further analysis will identify potential treatment targets and whether there are any drugs that could be used for these particular mutations. Follow up clinical data will be assessed to see if this individualized method of choosing treatment options can improve clinical outcomes in patients with GBM.

Conditions

Interventions

OTHER

Observational study, no intervention

Observational study, no intervention

Sponsors & Collaborators

  • Memorial Sloan Kettering Cancer Center

    collaborator OTHER

  • Lenox Hill Hospital

    collaborator OTHER

  • North Shore University Hospital

    collaborator OTHER

  • NYU Langone Health

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Albert Einstein College of Medicine

    collaborator OTHER

  • New York Genome Center

    collaborator OTHER

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Robert Darnell, MD, PhD · Rockefeller University

Eligibility

Min Age
3 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-12
Primary Completion
2017-07-07
Completion
2017-07-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725684 on ClinicalTrials.gov